Thinking beyond GLP-1: the role of formoline L112 in modern weight management
12 Oct 2026
Business & Services Theatre
GLP-1 therapies have transformed the weight-management conversation, but they are not the whole answer. Many patients need support before starting treatment, an alternative when injectables are not suitable, and a way to maintain results afterwards. This session examines where an oral, clinically proven fat binder fits into modern weight management. Drawing on formoline L112's evidence base and its position as Germany's number one OTC anti-obesity product, it explores the product's role as a well-tolerated, non-prescription option and its place alongside and beyond GLP-1 therapy in everyday pharmacy practice.
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
.png/fit-in/1280x9999/filters:no_upscale()){kind=logo}
){kind=logo}
)
)
){kind=logo}
)
)
)
)
)
)
)